Oxford Bioscience Partners III Lp

Avg. Two Year Performance

No purchase track record

23% Avg. Sale Return

11% Compound

	1 Mo	3 Mo	6 Mo	1 Yr	2 Yr
Average Purchase Return	--	--	--	--	--
Purchase Success Rate	--	--	--	--	--
Average Sale Return	(3%)	(2%)	15%	32%	23%
Sale Success Rate	0 of 1	0 of 1	1 of 1	1 of 1	1 of 1

Avalon Pharmaceuticals, Inc.

Drugs » Diagnostic Substances

10% Owner:

Holdings: 841.14K shares

Sentiment

Avg. Two Year Performance

No purchase track record

No sale track record

Last Three Months:

0 Net Amount

Buy:	0	--
Sell:	0	--